Back to Journals » Drug Design, Development and Therapy » Volume 16

Quality of Evidence Supporting the Role of Tripterygium Glycosides for the Treatment of Diabetic Kidney Disease: An Overview of Systematic Reviews and Meta-Analyses [Corrigendum]

Authors Shi H , Deng P, Dong C, Lu R, Si G, Yang T 

Received 19 October 2022

Accepted for publication 19 October 2022

Published 21 October 2022 Volume 2022:16 Pages 3675—3676

DOI https://doi.org/10.2147/DDDT.S394057



Shi H, Deng P, Dong C, Lu R, Si G, Yang T. Drug Des Devel Ther. 2022;16:1647–1665.

The authors have advised affiliation 4 on page 1647 is incorrect. The correct affiliation should read “4Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China”.

The authors apologize for this error.


Read the original article


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.